Knowledge is power

Latest developments at PurSolutions

Follow us on social media for the most up-to-date news about PurSolutions and exciting cytoskeleton protein content.

Microtubule-destabilizing SARS-CoV-2 Drug clears Phase III

Sabizabulin (VERU-111), an novel microtubule inhibitor, significantly reduced mortality in hospitalized patients with moderate to severe Covid-19 at high risk for acute respiratory distress syndrome and death according to an interim analysis from a randomized, global phase 3 clinical trial published this week in The New England Journal of Medicine Evidence.

Read More »

PurSolutions’ 2021 Reagent Scholarship Recipient Announcement

After reviewing many exceptional applications, our panel has selected the recipient of the PurSolutions’ 2021 Reagent Scholarship: Mr. Narendran Annadurai Graduate Student Palacky University Olomouc Czech Republic Mr. Annadurai is pursuing the development of tau aggregation inhibitors for neurodegenerative diseases including Alzheimer’s disease.  He will primarily be using in vitro aggregation assays and microscopy techniques.

Read More »

Small molecule tubulin inhibitor for COVID-19 treatment

As discussed in our previous article back in March 2020, it has been shown that coronavirus spike proteins interact with cytoskeleton filaments (i.e. microtubules and actin) for internalization into host cells – a critical step in viral pathogenesis. It has also been shown for some coronaviruses that targeting the cytoskeleton with tubulin or actin inhibitors

Read More »

COVID-19 Services – Expediting Research

Dear Researchers, In light of the rapidly changing global health situation resulting from the COVID-19 virus, PurSolutions is committed to supporting researchers in their efforts to discover more about the virus and bring us closer to an effective vaccine or treatment. As you may know, the structure of the COVID-19 spike protein was discovered a

Read More »

PurSolutions Announces Recipient of 2019 Reagent Scholarship

Ashley Arthur, a 5th year graduate student at the University of Minnesota, has been selected as the recipient of PurSolutions’ 2019 Reagent Scholarship. As a lab member in Dr. Titus’ lab, Ashley has been allowed to pursue her passion and curiosity of molecular motors and the cytoskeleton. Ashley states that Dr. Titus and the University

Read More »

Launch Tennessee awards 12 Tennessee companies with SBIR/STTR Grant Matching Funds

PurSolutions, LLC is one of the 12 recipients selected to receive LaunchTN Funding. Nashville, Tenn. –  On January 8, 2019, Launch Tennessee (LaunchTN) announced the 12 selected recipients of the Tennessee Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR) Matching Fund Grant program. LaunchTN is developed and funded by the Tennessee Department of Economic

Read More »

PurSolutions co-founders Dr. Emma Sturgill and Mr. Beattie Sturgill present their “lessons learned” to the National Science Foundation

Emma and Beattie attended and presented at the NSF SBIR/STTR Phase I Grantee Workshop held on March 19th-21st, 2018 in Arlington, VA. The workshop included featured speakers, entrepreneurial networking, presentations, and the Phase I “Beat-the-Odds Boot Camp”. The NSF Boot Camp provides an immersive experience that pushes companies to develop stronger business models, market strategies,

Read More »

PurSolutions sponsors biophysics conference

PurSolutions, LLC financially contributed to the Biophysical Society Annual Meeting in San Francisco, CA to help support the Motility and Cytoskeleton subgroup chaired by Carolyn Moores and Kristen Verhey.

Read More »

If you would like to contribute, send in your comments.

Scroll to Top